109 related articles for article (PubMed ID: 3569439)
1. Effect of cryopreservation on purging of leukemic marrow with alkyl-lysophospholipids.
Vogler WR; Somberg LB; Glasser L
Exp Hematol; 1987 May; 15(4):360-4. PubMed ID: 3569439
[TBL] [Abstract][Full Text] [Related]
2. Purging leukemia remission marrows with alkyl-lysophospholipids, preclinical and clinical results.
Vogler WR; Olson AC; Berdel WE; Okamoto S; Glasser L
Prog Clin Biol Res; 1990; 333():1-18; discussion 19-20. PubMed ID: 2308973
[TBL] [Abstract][Full Text] [Related]
3. The cytotoxicity of alkyl-lysophospholipid on clonogenic leukemia cells and on normal bone marrow progenitor cells is highly, but differentially, increased by cryopreservation.
Verdonck LF; Heesbeen EC; van Heugten HG; Staal GE; Rijksen G
Bone Marrow Transplant; 1992 Apr; 9(4):241-5. PubMed ID: 1600412
[TBL] [Abstract][Full Text] [Related]
4. Experimental studies on the role of alkyl lysophospholipids in autologous bone marrow transplantation.
Vogler WR; Olson AC; Okamoto S; Somberg LB; Glasser L
Lipids; 1987 Nov; 22(11):919-24. PubMed ID: 3328027
[TBL] [Abstract][Full Text] [Related]
5. Purging murine leukemic marrow with alkyl-lysophospholipids.
Glasser L; Somberg LB; Vogler WR
Blood; 1984 Dec; 64(6):1288-91. PubMed ID: 6388666
[TBL] [Abstract][Full Text] [Related]
6. The effect of a combined purging with mafosfamide and hyperthermia on murine haemopoietic stem cells and leukaemogenic cells.
Gidáli J; Fehér I
Bone Marrow Transplant; 1992 Dec; 10(6):479-83. PubMed ID: 1490197
[TBL] [Abstract][Full Text] [Related]
7. In vitro chemoseparation of leukemic cells from murine bone marrow using VP16-213: importance of stem cell assays.
Stiff PJ; Koester AR
Exp Hematol; 1987 Mar; 15(3):263-8. PubMed ID: 3545881
[TBL] [Abstract][Full Text] [Related]
8. Purging leukemic cells from simulated human remission marrow with alkyl-lysophospholipid.
Okamoto S; Olson AC; Vogler WR; Winton EF
Blood; 1987 May; 69(5):1381-7. PubMed ID: 3471282
[TBL] [Abstract][Full Text] [Related]
9. Use of etoposide in combination with cyclosporin for purging multidrug-resistant leukemic cells from bone marrow in a mouse model.
Kühl JS; Sikic BI; Blume KG; Chao NJ
Exp Hematol; 1992 Oct; 20(9):1048-54. PubMed ID: 1468539
[TBL] [Abstract][Full Text] [Related]
10. Cryopreservation of autologous marrow grafts in acute leukemia: survival of in vivo clonogenic leukemic cells and normal hemopoietic stem cells.
Hagenbeek A; Martens AC
Leukemia; 1989 Jul; 3(7):535-7. PubMed ID: 2659904
[TBL] [Abstract][Full Text] [Related]
11. Comparative heat sensitivity of murine and human hemopoietic progenitors and clonogenic leukemia cells.
Gidáli J; Fehér I; Kovács P
Stem Cells; 1994 Sep; 12(5):533-8. PubMed ID: 7804126
[TBL] [Abstract][Full Text] [Related]
12. Hyperthermic purging in vitro of murine leukemia cells (MK-8057): surviving fractions of normal and leukemic stem cells and the long-term survival of mice injected with the post-hyperthermic leukemia cells.
Iwasawa T; Hirabayashi Y; Kubota N; Inoue T; Kakehi M; Matsui K
Exp Hematol; 1991 Jun; 19(5):332-7. PubMed ID: 2026185
[TBL] [Abstract][Full Text] [Related]
13. Purging of leukemia-contaminated bone marrow grafts using suicide adenoviral vectors: an in vivo murine experimental model.
Garcia-Castro J; Rio P; Lillo R; Garcia-Sanchez F; Segovia JC; Bueren JA
Gene Ther; 2003 Aug; 10(16):1328-35. PubMed ID: 12883529
[TBL] [Abstract][Full Text] [Related]
14. Clonogenic leukemic progenitor cells in acute myelocytic leukemia are highly sensitive to cryopreservation: possible purging effect for autologous bone marrow transplantation.
Allieri MA; Lopez M; Douáy L; Mary JY; NGuyen L; Gorin NC
Bone Marrow Transplant; 1991 Feb; 7(2):101-5. PubMed ID: 2049553
[TBL] [Abstract][Full Text] [Related]
15. The detection of normal hidden stem cells during the development of leukemia: assays with PGK isozyme.
Hirabayashi Y; Inoue T; Yoshida K; Inayama Y; Kanisawa M
Exp Hematol; 1990 Jan; 18(1):7-10. PubMed ID: 2298274
[TBL] [Abstract][Full Text] [Related]
16. Differential sensitivity of AKR murine leukemia and normal bone marrow cells to hyperthermia.
Robins HI; Steeves RA; Clark AW; Martin PA; Miller K; Dennis WH
Cancer Res; 1983 Oct; 43(10):4951-5. PubMed ID: 6883345
[TBL] [Abstract][Full Text] [Related]
17. Antileukemic effect of interleukin-2-transduced murine bone marrow after autologous transplantation.
Tam YK; Klingemann HG
Biol Blood Marrow Transplant; 1999; 5(4):231-42. PubMed ID: 10465103
[TBL] [Abstract][Full Text] [Related]
18. Toxic effects of alkyl-lysophospholipids on human bone marrow and de novo leukaemias. A short overview.
Wötzel M; Brachwitz H; Langen P; Thierbach V
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):771-6. PubMed ID: 1713880
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents.
Neben S; Hellman S; Montgomery M; Ferrara J; Mauch P
Exp Hematol; 1993 Jan; 21(1):156-62. PubMed ID: 8435103
[TBL] [Abstract][Full Text] [Related]
20. Goralatide (AcSDKP) selectively protects murine hematopoietic progenitors and stem cells against hyperthermic damage.
Wierenga PK; Konings AW
Exp Hematol; 1996 Feb; 24(2):246-52. PubMed ID: 8641348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
